Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L Blust
Bortezomib-Based Induction for Transplant Ineligible AL Amyloidosis and Feasibility of Later Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Autologous Stem Cell Transplant in the Era of Bortezomib-Based Induction for AL Amyloidosis – A Single Institution 11 Year Experience
Efficacy of Bortezomib in Systemic AL Amyloidosis With Relapsed/Refractory Clonal Disease
Haematologica
Hematology
Combination of Bortezomib in the Induction, Conditioning and Consolidation With Autologous Hematopoietic Stem Cell Transplantation in Patients With Immunoglobulin Light Chain Amyloidosis
American Journal of Hematology
Hematology
Maintained Hematologic and Organ Responses Following Risk Adapted Stem Cell Transplant (SCT) in Systemic Light-Chain Amyloidosis (AL) Using Bortezomib and Dexamethasone as Consolidation Therapy
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Response of Bortezomib Chemotherapy in Hepatic Amyloidosis
Journal of Investigative Medicine High Impact Case Reports
Risk
Epidemiology
Reliability
Safety
Safety Research
Quality
Bortezomib and Dexamethasone Consolidation Following Risk-Adapted Melphalan and Stem Cell Transplantation for Patients With Newly Diagnosed Light-Chain Amyloidosis
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
The Influence of Induction Therapy for Kidney Transplantation After a Non-Renal Transplant
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
Orthotopic Heart Transplant Facilitated Autologous Hematopoietic Stem Cell Transplantation in Light-Chain Amyloidosis
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
New and Developing Therapies for AL Amyloidosis
Expert Opinion on Pharmacotherapy
Medicine
Pharmacology
